Empaveli (pegcetacoplan SC) - SOBI, Biogen
Pre- and Post-Transplant Pegcetacoplan: A Novel Approach to Preventing C3 Glomerulopathy Recurrence (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO1158; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "This case demonstrates a paradigm shift from reactive treatment of C3G to proactive prevention. By addressing the underlying pathophysiology of complement inhibition before allograft injury occurs, this treatment strategy offers significant promise for high-risk transplant candidates with C3G." 
Post-transplantation • Complement-mediated Rare Disorders • Glomerulonephritis • Lupus Nephritis • Nephrology • Transplantation
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4557502
 
Jaya S. Parulekar; Cybele Ghossein; Akansha Agrawal; Awsse Al-Ani
 
Oct 2, 2026
 
Prev Next